Typhoid vaccine

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Typhoid vaccine
Accession Number
DB14022
Description
Not Available
Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Other vaccines
Synonyms
Not Available

Pharmacology

Indication
Not Available
Associated Conditions
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbataceptThe therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Abatacept.
Acetic acidThe therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Acetic acid.
Acetyl sulfisoxazoleThe therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Acetyl sulfisoxazole.
AdalimumabThe therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Adalimumab.
AldesleukinThe therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Aldesleukin.
AlefaceptThe therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Alefacept.
AlemtuzumabThe therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Alemtuzumab.
AltretamineThe therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Altretamine.
AmikacinThe therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Amikacin.
Aminosalicylic acidThe therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Aminosalicylic acid.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

Products

Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Typhoid VaccineSuspensionSubcutaneousAventis Pasteur Limited1973-11-302000-11-14Canada
Vivotif-BCapsule2 [CFU]/1OralRebel Distributors Corp1989-12-15Not applicableUs
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
Not Available
CAS number
Not Available

References

General References
Not Available
Wikipedia
Typhoid_vaccine

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4RecruitingBasic ScienceRisk Reduction1
4RecruitingPreventionAging / Inflammatory Reaction1
3CompletedPreventionHepatitis A / Salmonella Typhi Infection / Viral Hepatitis B1
3RecruitingPreventionSalmonella Typhi Infection1
1RecruitingPreventionCardiovascular Heart Disease1
0CompletedBasic ScienceCardiovascular Function1
Not AvailableCompletedBasic ScienceTyphoid Vaccine on Sleep1
Not AvailableRecruitingBasic ScienceCognitive Side Effects of Cancer Therapy / Depression / Recurrent Breast Carcinoma / Stage IA Breast Cancer / Stage IB Breast Cancer / Stage IIA Breast Cancer / Stage IIB Breast Cancer / Stage IIIA Breast Cancer1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
SuspensionSubcutaneous
CapsuleOral2 [CFU]/1
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available

Drug created on May 14, 2018 11:07 / Updated on June 12, 2020 11:42

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates